Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Christensen

Showing results (501-510 of 522) with videos related to

Pageof 53
Sort By:
Seminars in Arthritis and Rheumatism|April 20, 2021
OMERACT consensus-based operational definition of contextual factors in rheumatology clinical trials: A mixed methods studySabrina Mai Nielsen, Maarten Boers, Maarten de Wit, et al.
Rheumatology (Oxford, England)|July 16, 2015
Effectiveness and drug adherence of biologic monotherapy in routine care of patients with rheumatoid arthritis: a cohort study of patients registered in the Danish biologics registryTanja Schjødt Jørgensen, Lars Erik Kristensen, Robin Christensen, et al.
The Journal of Rheumatology|January 17, 2019
The OMERACT-OARSI Core Domain Set for Measurement in Clinical Trials of Hip and/or Knee OsteoarthritisToby O Smith, Gillian A Hawker, David J Hunter, et al.
The Journal of Rheumatology|March 3, 2019
Uptake of the OMERACT-OARSI Hip and Knee Osteoarthritis Core Outcome Set: Review of Randomized Controlled Trials from 1997 to 2017Toby O Smith, Michael Mansfield, Gillian A Hawker, et al.
Journal of Clinical Epidemiology|April 9, 2017
GRADE equity guidelines 3: considering health equity in GRADE guideline development: rating the certainty of synthesized evidenceVivian A Welch, Elie A Akl, Kevin Pottie, et al.
The Journal of Rheumatology|August 3, 2017
Toward the Development of a Core Set of Outcome Domains to Assess Shared Decision-making Interventions in Rheumatology: Results from an OMERACT Delphi Survey and Consensus MeetingKarine Toupin-April, Jennifer Barton, Liana Fraenkel, et al.
The Journal of Rheumatology|February 3, 2019
OMERACT Development of a Core Domain Set of Outcomes for Shared Decision-making InterventionsKarine Toupin-April, Jennifer L Barton, Liana Fraenkel, et al.
Eclinicalmedicine|October 25, 2023
A framework for the definition and interpretation of the use of surrogate endpoints in interventional trialsOriana Ciani, Anthony M Manyara, Philippa Davies, et al.
BMJ (Clinical Research Ed.)|July 9, 2024
Reporting of surrogate endpoints in randomised controlled trial protocols (SPIRIT-Surrogate): extension checklist with explanation and elaborationAnthony Muchai Manyara, Philippa Davies, Derek Stewart, et al.
BMJ (Clinical Research Ed.)|July 9, 2024
Reporting of surrogate endpoints in randomised controlled trial reports (CONSORT-Surrogate): extension checklist with explanation and elaborationAnthony Muchai Manyara, Philippa Davies, Derek Stewart, et al.
Pageof 53

Showing results (501-510 of 522) with videos related to

Sort By:
Pageof 53
Seminars in Arthritis and Rheumatism|April 20, 2021
OMERACT consensus-based operational definition of contextual factors in rheumatology clinical trials: A mixed methods studySabrina Mai Nielsen, Maarten Boers, Maarten de Wit, et al.
Rheumatology (Oxford, England)|July 16, 2015
Effectiveness and drug adherence of biologic monotherapy in routine care of patients with rheumatoid arthritis: a cohort study of patients registered in the Danish biologics registryTanja Schjødt Jørgensen, Lars Erik Kristensen, Robin Christensen, et al.
The Journal of Rheumatology|January 17, 2019
The OMERACT-OARSI Core Domain Set for Measurement in Clinical Trials of Hip and/or Knee OsteoarthritisToby O Smith, Gillian A Hawker, David J Hunter, et al.
The Journal of Rheumatology|March 3, 2019
Uptake of the OMERACT-OARSI Hip and Knee Osteoarthritis Core Outcome Set: Review of Randomized Controlled Trials from 1997 to 2017Toby O Smith, Michael Mansfield, Gillian A Hawker, et al.
Journal of Clinical Epidemiology|April 9, 2017
GRADE equity guidelines 3: considering health equity in GRADE guideline development: rating the certainty of synthesized evidenceVivian A Welch, Elie A Akl, Kevin Pottie, et al.
The Journal of Rheumatology|August 3, 2017
Toward the Development of a Core Set of Outcome Domains to Assess Shared Decision-making Interventions in Rheumatology: Results from an OMERACT Delphi Survey and Consensus MeetingKarine Toupin-April, Jennifer Barton, Liana Fraenkel, et al.
The Journal of Rheumatology|February 3, 2019
OMERACT Development of a Core Domain Set of Outcomes for Shared Decision-making InterventionsKarine Toupin-April, Jennifer L Barton, Liana Fraenkel, et al.
Eclinicalmedicine|October 25, 2023
A framework for the definition and interpretation of the use of surrogate endpoints in interventional trialsOriana Ciani, Anthony M Manyara, Philippa Davies, et al.
BMJ (Clinical Research Ed.)|July 9, 2024
Reporting of surrogate endpoints in randomised controlled trial protocols (SPIRIT-Surrogate): extension checklist with explanation and elaborationAnthony Muchai Manyara, Philippa Davies, Derek Stewart, et al.
BMJ (Clinical Research Ed.)|July 9, 2024
Reporting of surrogate endpoints in randomised controlled trial reports (CONSORT-Surrogate): extension checklist with explanation and elaborationAnthony Muchai Manyara, Philippa Davies, Derek Stewart, et al.
Pageof 53